These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7504426)

  • 21. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antenatal screening for Down's syndrome.
    Spencer K; Macri JN; Coombes EJ; Ward AM
    BMJ; 1993 Jun; 306(6892):1616. PubMed ID: 7687179
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving methods of screening for Down's syndrome.
    White I; Papiha SS; Magnay D
    N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139
    [No Abstract]   [Full Text] [Related]  

  • 26. Making sense of maternal serum screening.
    Lindsay P
    Nurs Times; 1994 Dec 7-14; 90(49):30-2. PubMed ID: 7528377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomograms to help inform women considering Down's syndrome screening.
    Cuckle HS; Sehmi IK; Holding S
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):69-72. PubMed ID: 8902435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal Down's screening test associated with severe hyperemesis gravidarum.
    Pradhan P; Mohajer M
    J Obstet Gynaecol; 2002 Nov; 22(6):692. PubMed ID: 12554274
    [No Abstract]   [Full Text] [Related]  

  • 32. Improved antenatal screening for Down's syndrome.
    Benn P
    Lancet; 2003 Mar; 361(9360):794-5. PubMed ID: 12642040
    [No Abstract]   [Full Text] [Related]  

  • 33. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seeking other disorders within antenatal serum screening programmes for Down's syndrome.
    Wald NJ; Canick JA
    J Med Screen; 2002; 9(4):145-6. PubMed ID: 12518002
    [No Abstract]   [Full Text] [Related]  

  • 35. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities.
    Wright DE; Reynolds TM; Donovan CM
    Ann Clin Biochem; 1993 Nov; 30 ( Pt 6)():578-83. PubMed ID: 7508213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
    Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
    Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
    J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
    [No Abstract]   [Full Text] [Related]  

  • 39. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Median parameters for Down's syndrome screening should be calculated using a moving time-window method.
    Reynolds TM; Aldis J
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):567-70. PubMed ID: 18768535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.